Thanks to “big data”, researchers have identified new molecules that are instrumental in the replication of the flu virus. If these host proteins are blocked, influenza viruses are unable to multiply as effectively. The international study therefore makes a significant contribution towards the development of new treatments and flu drugs.
Flu epidemics occur almost every year. Sometimes, novel virus strains can even spread into global pandemics. In recent years, influenza A viruses (IAV) have been discovered that are resistant to the drugs available to treat flu, which can result in patients not responding to the medication.
The flu is triggered by infections with influenza viruses, which multiply heavily in the respiratory tract. In order to replicate within the cells of the respiratory tract, the viruses rely on host molecules. In recent years, there have thus been attempts to identify and block key host molecules for this process in order to stop the virus in its tracks.
Inhibition of host proteins curbs viral growth
An international study, in which the University of Zurich is involved, also pursues this approach. The research teams from Switzerland, Germany and the USA analyzed datasets from independent publications on IAV host molecules. These studies focus on the totality of the genes (“GenOMICs”) and proteins (ProteOMICs”) required for the virus and generate a vast quantity of data. Thanks to the comprehensive analysis of these “OMIC” databases, 20 previously unknown host molecules that promote the growth of influenza A viruses have been discovered.
“These unchangeable host proteins are vital for the replication of the viruses,” explains Professor Silke Stertz from the Institute of Medical Virology at the University of Zurich. “We can now use these to stop the virus from spreading further.” One of these host proteins is UBR4, which the virus needs to transport viral proteins to the cell membrane and construct new particles. This takes place as follows: The influenza A virus invades the host cell. The viral components are then carried to the cell surface, where they form new viruses. Consequently, as many as 20,000 new influenza viruses can develop from one, single infected host cell.
The study reveals that blocking UBR4 inhibits the production of new virus particles in infected cells. In mice, for instance, the IAV replication could be weakened and the progress of the disease slowed. The study therefore provides evidence that blocking host molecules is feasible as a therapeutic strategy for the treatment of influenza.
Public web portal supports drug development
The research team created a simplified, user-friendly web portal (www.metascape.org/IAV) on influenza and host interaction. The site is also accessible to other researchers, enables individual requests and provides analysis tools to trace host proteins that are probably involved in the flu infection. As a result, the data published may help develop the next generation of influenza medication.
“We expect the approach described in this study and the use of ‘big data’ to bridge the gap between biomedical research and therapeutic development, and facilitate fresh insights into previously unanswered medical questions,” says co-author Sumit Chanda from Sanford Burnham Prebys Medical Discovery Institute (SBP) in California.
Shashank Tripathi, Marie O. Pohl, ….,Silke Stertz et al.: Meta- and Orthogonal Integration of Influenza 'OMICs' Data Reveals UBR4 as a Critical Regulator of M2 Ion Channel Membrane Trafficking. Cell Host & Microbe, December 9, 2015.
Institute of Medical Virology
University of Zurich
Melanie Nyfeler | Universität Zürich
New RNA sequencing strategy provides insight into microbiomes
17.12.2018 | University of Chicago Medical Center
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
17.12.2018 | Physics and Astronomy
17.12.2018 | Architecture and Construction
17.12.2018 | Life Sciences